| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |